EU Regulators Developing Tools For ‘N-Of-1’ Drugs & Platform Technologies

European regulators are working with global partners to tackle challenges that sponsors face during “N-of-1” trials, where medicines are personalized to the individual, and looking at the regulation of platform technologies.